Recombinant Human Insulin — FDA Animal & Veterinary Adverse Event (ADE) Reports
Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Recombinant Human Insulin is a active ingredient.
Total reports
Recombinant Human Insulin: 1670
Reports by species (top entries)
- Dog 1021
- Cat 471
- Human 7
- 6
Top reported reactions (VEDDRA terms, top entries)
- Vomiting 223
- Lack of efficacy - NOS 182
- Lethargy (see also Central nervous system depression in 'Neurological') 176
- INEFFECTIVE, GLYCEMIC CONTROL 159
- Hypoglycaemia 158
- Decreased appetite 98
- Uncoded sign 84
- Cataract 69
- Suspension, Abnormal 69
- Diarrhoea 68
Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b14.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).